Enliven Therapeutics (ELVN) Net Cash Flow (2019 - 2026)
Enliven Therapeutics (ELVN) reported Net Cash Flow of $3.32 million for Q2 2026, down 81.3% from $17.73 million a year earlier and down 90.0% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Net Cash Flow (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enliven Therapeutics' Net Cash Flow came in at $16.07 million, down 28.6% year-over-year; for FY2025, it was -$25.28 million.
- By year, Net Cash Flow came in at $23.98 million in FY2024 (-2.6%), $24.61 million in FY2023, -$34.49 million in FY2022 and $698,000 in FY2021 (-98.4%).
- Five-year quarterly Net Cash Flow spans a low of -$166.39 million in Q2 2023 and a high of $216.57 million in Q1 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at $33.29 million (Q1 2026), -$2.84 million (Q4 2025) and -$17.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Enliven Therapeutics | 3.36 Bn | 3.36 Bn | - | 3.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.32 Mn |
| Mar 31, 2026 | 33.29 Mn |
| Dec 31, 2025 | -2.84 Mn |
| Sep 30, 2025 | -17.71 Mn |
| Jun 30, 2025 | 17.73 Mn |
| Mar 31, 2025 | -22.47 Mn |
| Dec 31, 2024 | 23.50 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | -52.29 Mn |
| Mar 31, 2024 | 49.02 Mn |
| Dec 31, 2023 | 26.29 Mn |
| Sep 30, 2023 | -51.87 Mn |
| Jun 30, 2023 | -166.39 Mn |
| Mar 31, 2023 | 216.57 Mn |
| Dec 31, 2022 | -10.62 Mn |
| Sep 30, 2022 | -6.30 Mn |
| Jun 30, 2022 | -7.42 Mn |
| Mar 31, 2022 | -10.15 Mn |
| Dec 31, 2021 | -26.99 Mn |
| Sep 30, 2021 | 27.26 Mn |
API Access
Enliven Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();